ATE341537T1 - Dolastatin 10 derivate - Google Patents

Dolastatin 10 derivate

Info

Publication number: ATE341537T1
Authority: AT; Austria
Prior art keywords: dolastatin; derivatives
Prior art date: 2001-07-19

Application number

AT02764710T

Other languages

English (en)

Inventor

Toshihiko Fujii

Takehiro Okada

Mikio Taniguchi

Fumio Watanabe

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-19

Filing date

2002-07-17

Publication date

2006-10-15

2002-07-17 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2006-10-15 Application granted granted Critical

2006-10-15 Publication of ATE341537T1 publication Critical patent/ATE341537T1/de

Links

OFDNQWIFNXBECV-VFSYNPLYSA-N dolastatin 10 Chemical class CC(C)[C@H](N(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C=1SC=CN=1)CC1=CC=CC=C1 OFDNQWIFNXBECV-VFSYNPLYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Crystallography & Structural Chemistry (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT02764710T 2001-07-19 2002-07-17 Dolastatin 10 derivate ATE341537T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01117410		2001-07-19

Publications (1)

Publication Number	Publication Date
ATE341537T1 true ATE341537T1 (de)	2006-10-15

Family

ID=8178073

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02764710T ATE341537T1 (de)	2001-07-19	2002-07-17	Dolastatin 10 derivate

Country Status (30)

Country	Link
US (1)	US6737409B2 (de)
EP (1)	EP1412328B1 (de)
JP (1)	JP2004534859A (de)
KR (2)	KR20060057652A (de)
CN (1)	CN1553897A (de)
AR (1)	AR036175A1 (de)
AT (1)	ATE341537T1 (de)
BR (1)	BR0211289A (de)
CA (1)	CA2453987A1 (de)
CO (1)	CO5550462A2 (de)
DE (1)	DE60215179T2 (de)
DK (1)	DK1412328T3 (de)
ES (1)	ES2272763T3 (de)
GT (1)	GT200200154A (de)
HR (1)	HRP20040043A2 (de)
HU (1)	HUP0401253A2 (de)
IL (1)	IL159890A0 (de)
MX (1)	MXPA04000577A (de)
MY (1)	MY127718A (de)
NO (1)	NO20040198L (de)
NZ (1)	NZ530655A (de)
PA (1)	PA8551001A1 (de)
PE (1)	PE20030258A1 (de)
PL (1)	PL367682A1 (de)
PT (1)	PT1412328E (de)
RU (1)	RU2296750C2 (de)
SI (1)	SI1412328T1 (de)
UY (1)	UY27388A1 (de)
WO (1)	WO2003008378A1 (de)
ZA (1)	ZA200400334B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7256257B2 (en)	2001-04-30	2007-08-14	Seattle Genetics, Inc.	Pentapeptide compounds and uses related thereto
US7192972B2 (en)	2002-03-22	2007-03-20	Eisai Co., Ltd.	Hemiasterlin derivatives and uses thereof
US7064211B2 (en)	2002-03-22	2006-06-20	Eisai Co., Ltd.	Hemiasterlin derivatives and uses thereof
DK1545613T3 (da)	2002-07-31	2011-11-14	Seattle Genetics Inc	Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom
CN107213469A (zh)	2003-11-06	2017-09-29	西雅图基因公司	能够与配体偶联的单甲基缬氨酸化合物
CA2567914A1 (en) *	2004-06-02	2005-12-15	F. Hoffmann-La Roche Ag	Synthesis of amino-alkoxy-heptanoic alkyl ester
EP3505191A1 (de)	2004-11-12	2019-07-03	Seattle Genetics, Inc.	Auristatine mit einer aminobenzoesäureeinheit am n-ende
EP1827603A2 (de) *	2004-12-13	2007-09-05	F. Hoffmann-Roche AG	Neue pharmazeutische zusammensetzung mit mindestens einem dolastatin-10-derivat
KR20070086128A (ko) *	2004-12-13	2007-08-27	에프. 호프만-라 로슈 아게	3-피롤리딘-2-일-프로피온산 유도체의 신규 제조 방법
US20060161076A1 (en) *	2005-01-06	2006-07-20	Diamics, Inc.	Systems and methods for collection of cell clusters
US20060189893A1 (en) *	2005-01-06	2006-08-24	Diamics, Inc.	Systems and methods for detecting abnormal cells
JP2008526908A (ja) *	2005-01-13	2008-07-24	エフ．ホフマン−ラロシュアーゲー	有用な二置換アミンの新規な一段合成法
EP1883627B1 (de)	2005-05-18	2018-04-18	Pharmascience Inc.	An die bir-domäne bindende verbindungen
US8871720B2 (en)	2005-07-07	2014-10-28	Seattle Genetics, Inc.	Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
WO2007008603A1 (en)	2005-07-07	2007-01-18	Seattle Genetics, Inc.	Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus
US7750116B1 (en)	2006-02-18	2010-07-06	Seattle Genetics, Inc.	Antibody drug conjugate metabolites
WO2007131366A1 (en)	2006-05-16	2007-11-22	Aegera Therapeutics Inc.	Iap bir domain binding compounds
US20080003652A1 (en) *	2006-06-28	2008-01-03	Hans Iding	Novel enzymatic process for the manufacture of Boc-Dap-Oh priority to related application(s)
NZ583367A (en)	2007-07-16	2012-10-26	Genentech Inc	Anti-cd79b antibodies and immunoconjugates and methods of use
CL2008002083A1 (es)	2007-07-16	2008-11-21	Genentech Inc	Anticuerpo humanizado anti-cd79b/igbeta/b29; inmunoconjugado; metodo in vitro para determinar presencia de cd79b, inhibir crecimiento de celula con cd79b, o para detectara celula b; metodo para elaborar dicho anticyerpo humanizado; acido nucleico; celula huesped; composicion; metodo de elaboracion de inmunoconjugado; uso medico
ES2643239T3 (es)	2008-01-31	2017-11-21	Genentech, Inc.	Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso
DK2265283T3 (da)	2008-03-18	2014-10-20	Seattle Genetics Inc	Auristatin-lægemiddel-linker-konjugater
WO2011100403A1 (en)	2010-02-10	2011-08-18	Immunogen, Inc	Cd20 antibodies and uses thereof
SG182724A1 (en)	2010-02-12	2012-08-30	Pharmascience Inc	Iap bir domain binding compounds
CN103200950B (zh)	2010-06-10	2016-03-16	西雅图基因公司	新颖的耳他汀衍生物及其用途
ES2553874T3 (es)	2010-09-29	2015-12-14	Seattle Genetics, Inc.	N-Carboxialquil-auristatinas y su uso
JP6023097B2 (ja) *	2011-03-16	2016-11-09	シアトルジェネティックス，インコーポレイテッド	Ｎカルボキシアルキルオーリスタチンおよびその使用
EP2714685B1 (de) *	2011-05-27	2016-10-19	Ambrx, Inc.	Zusammensetzungen, enthaltend mit nichtnatürlichen aminosäuren verknüpfte dolastatin-derivate, sowie verfahren dafür und anwendungen davon
KR102179369B1 (ko)	2011-05-27	2020-11-16	암브룩스, 인코포레이티드	비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
WO2014046441A1 (ko)	2012-09-20	2014-03-27	(주)셀트리온	돌라스타틴 10 유도체, 그의 제조방법 및 그를 포함하는 항암제 조성물
DK3086815T3 (da)	2013-12-27	2022-05-23	Zymeworks Inc	Sulfonamidholdige forbindelsessystemer til lægemiddelkonjugater
DK3262071T3 (da)	2014-09-23	2020-06-15	Hoffmann La Roche	Fremgangsmåde til anvendelse af anti-CD79b-immunkonjugater
CN105949277B (zh) *	2015-05-05	2019-03-01	成都永泰诺科技有限公司	一种抗肿瘤化合物及其用途
BR112018016008A2 (pt) *	2016-03-29	2018-12-18	Toray Industries, Inc.	derivado de peptídeo ou o sal farmaceuticamente aceitável do mesmo, conjugado ou um sal farmaceuticamente aceitável do mesmo, e, agente citotóxico.
CN109021065B (zh) *	2017-06-08	2021-10-01	复旦大学	一种制备海兔毒素Dolastatin10的方法
AU2020223031B2 (en)	2019-02-12	2024-08-29	Ambrx, Inc.	Compositions containing, methods and uses of antibody-TLR agonist conjugates
CA3230737A1 (en)	2021-09-03	2023-03-09	Toray Industries, Inc.	Pharmaceutical composition for cancer treatment and/or prevention

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2700165B1 (fr) *	1993-01-07	1995-02-17	Rhone Poulenc Rorer Sa	Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
US6323315B1 (en)	1999-09-10	2001-11-27	Basf Aktiengesellschaft	Dolastatin peptides

2002
- 2002-07-15 US US10/195,698 patent/US6737409B2/en not_active Expired - Fee Related
- 2002-07-17 MX MXPA04000577A patent/MXPA04000577A/es active IP Right Grant
- 2002-07-17 CA CA002453987A patent/CA2453987A1/en not_active Abandoned
- 2002-07-17 DE DE60215179T patent/DE60215179T2/de not_active Expired - Fee Related
- 2002-07-17 MY MYPI20022704A patent/MY127718A/en unknown
- 2002-07-17 ES ES02764710T patent/ES2272763T3/es not_active Expired - Lifetime
- 2002-07-17 PT PT02764710T patent/PT1412328E/pt unknown
- 2002-07-17 BR BR0211289-2A patent/BR0211289A/pt not_active IP Right Cessation
- 2002-07-17 RU RU2004105145/04A patent/RU2296750C2/ru not_active IP Right Cessation
- 2002-07-17 PL PL02367682A patent/PL367682A1/xx not_active Application Discontinuation
- 2002-07-17 KR KR1020067008692A patent/KR20060057652A/ko not_active Ceased
- 2002-07-17 HU HU0401253A patent/HUP0401253A2/hu unknown
- 2002-07-17 DK DK02764710T patent/DK1412328T3/da active
- 2002-07-17 NZ NZ530655A patent/NZ530655A/en unknown
- 2002-07-17 KR KR1020047000854A patent/KR100611540B1/ko not_active Expired - Fee Related
- 2002-07-17 WO PCT/EP2002/007931 patent/WO2003008378A1/en not_active Ceased
- 2002-07-17 JP JP2003513938A patent/JP2004534859A/ja active Pending
- 2002-07-17 EP EP02764710A patent/EP1412328B1/de not_active Expired - Lifetime
- 2002-07-17 CN CNA028177622A patent/CN1553897A/zh active Pending
- 2002-07-17 SI SI200230447T patent/SI1412328T1/sl unknown
- 2002-07-17 IL IL15989002A patent/IL159890A0/xx unknown
- 2002-07-17 AR ARP020102678A patent/AR036175A1/es not_active Application Discontinuation
- 2002-07-17 AT AT02764710T patent/ATE341537T1/de not_active IP Right Cessation
- 2002-07-17 HR HR20040043A patent/HRP20040043A2/hr not_active Application Discontinuation
- 2002-07-17 UY UY27388A patent/UY27388A1/es not_active Application Discontinuation
- 2002-07-18 GT GT200200154A patent/GT200200154A/es unknown
- 2002-07-18 PA PA20028551001A patent/PA8551001A1/es unknown
- 2002-07-19 PE PE2002000643A patent/PE20030258A1/es not_active Application Discontinuation
2004
- 2004-01-15 ZA ZA2004/00334A patent/ZA200400334B/en unknown
- 2004-01-16 NO NO20040198A patent/NO20040198L/no not_active Application Discontinuation
- 2004-01-20 CO CO04003736A patent/CO5550462A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200400334B (en)	2005-06-29
RU2296750C2 (ru)	2007-04-10
PE20030258A1 (es)	2003-03-19
MXPA04000577A (es)	2004-04-20
SI1412328T1 (sl)	2007-02-28
ES2272763T3 (es)	2007-05-01
RU2004105145A (ru)	2005-07-10
PL367682A1 (en)	2005-03-07
MY127718A (en)	2006-12-29
UY27388A1 (es)	2003-01-31
NZ530655A (en)	2006-08-31
DK1412328T3 (da)	2007-02-12
PT1412328E (pt)	2007-01-31
PA8551001A1 (es)	2003-09-17
EP1412328A1 (de)	2004-04-28
BR0211289A (pt)	2004-08-03
DE60215179D1 (de)	2006-11-16
EP1412328B1 (de)	2006-10-04
KR20040023661A (ko)	2004-03-18
IL159890A0 (en)	2004-06-20
NO20040198L (no)	2004-02-19
CA2453987A1 (en)	2003-01-30
CO5550462A2 (es)	2005-08-31
JP2004534859A (ja)	2004-11-18
US20030055002A1 (en)	2003-03-20
US6737409B2 (en)	2004-05-18
HUP0401253A2 (hu)	2004-12-28
GT200200154A (es)	2003-05-16
AR036175A1 (es)	2004-08-18
WO2003008378A1 (en)	2003-01-30
HRP20040043A2 (en)	2004-08-31
CN1553897A (zh)	2004-12-08
KR100611540B1 (ko)	2006-08-10
KR20060057652A (ko)	2006-05-26
DE60215179T2 (de)	2007-10-18

Legal Events

Date

Code

Title

Description

2007-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1412328

Country of ref document: EP

2009-04-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE341537T1 (de)	2006-10-15	Dolastatin 10 derivate
FR20C1039I2 (fr)	2021-08-13	Derives de l'uk-2a
FR18C1024I2 (fr)	2019-05-17	Derives d'heterocyclocarboxamide
DE60218501D1 (de)	2007-04-12	Einstellbarer fixateur
ATE319451T1 (de)	2006-03-15	Tetrahydrochinolin-derivate
ATE312827T1 (de)	2005-12-15	3-substituierte-4-pyrimidonderivate
PT1411764E (pt)	2005-05-31	Cerca
ATE273980T1 (de)	2004-09-15	6-phenylpyrrolopyrimidindion derivate
EE200300447A (et)	2003-12-15	Asendatud bensofuraan-2-karboksamiidide derivaadid
ATE230405T1 (de)	2003-01-15	2-phenylpyran-4-one derivate
DE60202604D1 (de)	2005-02-17	Fischer-tropschverfahren
DE60223031D1 (de)	2007-11-29	Arylpiperazin gebundene tetrahydroindolonderivate
DE60220505D1 (de)	2007-07-19	Haarwaschmittel
DK1487778T3 (da)	2012-08-06	Substituerede 4 aminocyclohexanoler
MA27240A1 (fr)	2005-03-01	Derives d'imidazoquinoleine
DE60215804D1 (de)	2006-12-14	4-aminopyrimidine derivate
ATE382601T1 (de)	2008-01-15	Substituierte 4-aminocyclohexanolderivate
ATE496034T1 (de)	2011-02-15	Phtalazinon derivate
DK1392670T3 (da)	2005-08-08	Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater
DE60202381D1 (de)	2005-01-27	Paroxetin-n-formyl-derivate
EP1405844A4 (de)	2006-09-20	Cycloalkenonderivat
DE60207900D1 (de)	2006-01-19	"Suspend"-Paketübertrager
DE60103859D1 (de)	2004-07-22	2-phenylpyran-4-on derivate
DE50209548D1 (de)	2007-04-05	Substituierte 1-aryl-but-3-enylamin- und 1-aryl-but-2-enylaminverbindungen
ITRC20010003A1 (it)	2001-05-22	"fumanello"